Cyclopentolate and phenylephrine ophthalmic and Moxetumomab pasudotox
Determining the interaction of Cyclopentolate and phenylephrine ophthalmic and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyclopentolate / phenylephrine ophthalmic
Brand name: Cyclomydril
Synonyms: Cyclopentolate and Phenylephrine
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyclopentolate and phenylephrine ophthalmic-Moxetumomab Pasudotox-tdfk
- Cyclopentolate and phenylephrine ophthalmic-Moxetumomab pasudotox-tdfk Intravenous
- Cyclopentolate and phenylephrine ophthalmic-Moxifloxacin
- Cyclopentolate and phenylephrine ophthalmic-Moxifloxacin (Systemic)
- Cyclopentolate and phenylephrine ophthalmic-Moxifloxacin Hydrochloride
- Cyclopentolate and phenylephrine ophthalmic-Moxifloxacin Injection
- Moxetumomab pasudotox-Cyclopentolate Hydrochloride
- Moxetumomab pasudotox-Cyclopentolate ophthalmic
- Moxetumomab pasudotox-Cyclophosphamide
- Moxetumomab pasudotox-Cyclophosphamide Capsules
- Moxetumomab pasudotox-Cyclophosphamide Injection
- Moxetumomab pasudotox-Cyclophosphamide oral and injection